Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity

Author： Ginsberg Lawrence   Katic Alain   Adeyi Ben   Dirks Bryan   Babcock Thomas   Lasser Robert   Scheckner Brian   Adler Lenard A.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.6, 2011-06, pp. : 1097-1107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis

By Setyawan Juliana  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 962-975

Informa Healthcare

Access to resources Recommend Favorite

Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications

By Setyawan Juliana   Guérin Annie   Hodgkins Paul   Gauthier Geneviève   Cloutier Martin   Wu Eric   Haim Erder M.  

Journal of Medical Economics, Vol. 16, Iss. 11, 2013-11 ,pp. : 1275-1289

Informa Healthcare

Access to resources Recommend Favorite

Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder

By Turgay Atilla  

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 19-38

Future Medicine

Access to resources Recommend Favorite

Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment‐seeking adults

By  

DRUG AND ALCOHOL REVIEW, Vol. 34, Iss. 6, 2015-11 ,pp. : 683-693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Attention‐deficit/hyperactivity disorder symptoms in adults with self‐reported epilepsy: Results from a national epidemiologic survey of epilepsy

By  

EPILEPSIA, Vol. 56, Iss. 2, 2015-02 ,pp. : 218-224

John Wiley & Sons Inc

Access to resources Recommend Favorite